Pittsburgh, PA, United States of America

Joon S Lee

This inventor holds 1 USPTO granted patent. Top assignee: University of Pittsburgh. Active years: 2013.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joon S Lee: Innovator in Cell-Based Therapy

Introduction

Joon S Lee is a prominent inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of cell-based therapy, particularly through his innovative patent that focuses on improving therapeutic compositions.

Latest Patents

Joon S Lee holds a patent for "Directed cell-based therapy using microbubble tagged cells." This technology describes compositions and methods that are useful for providing cell-based therapy. One embodiment of this therapy involves the regeneration of injured tissue and promoting wound healing. The invention utilizes microbubbles to deliver biological progenitor cells to injured tissues, directed by acoustic radiation forces. This method enhances the efficiency of progenitor cell delivery, offering a personalized therapy approach that minimizes side effects and allergic reactions.

Career Highlights

Joon S Lee is affiliated with the University of Pittsburgh, where he continues to advance research in cell-based therapies. His work has garnered attention for its potential to revolutionize treatment methods for tissue injuries and wound healing.

Collaborations

Some of his notable coworkers include Xucai Chen and Catalin Toma, who contribute to the collaborative research environment at the University of Pittsburgh.

Conclusion

Joon S Lee's innovative work in directed cell-based therapy exemplifies the potential of personalized medicine. His contributions are paving the way for advancements in regenerative medicine and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…